Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
21.86
+0.84 (4.00%)
At close: Jan 13, 2026
HKG:2196 Market Cap
HKG:2196 has a market cap or net worth of 77.95 billion as of January 13, 2026. Its market cap has increased by 15.98% in one year.
Market Cap
77.95B
Enterprise Value
118.20B
Revenue
43.22B
Ranking
n/a
PE Ratio
21.73
Stock Price
21.86
Market Cap Chart
Since August 9, 2005, HKG:2196's market cap has increased from 4.19B to 77.95B, an increase of 1,758.16%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 76.67B | 5.84% |
| Dec 31, 2025 | 72.44B | 13.93% |
| Dec 31, 2024 | 63.58B | -6.29% |
| Dec 29, 2023 | 67.85B | -30.95% |
| Dec 30, 2022 | 98.27B | -29.69% |
| Dec 31, 2021 | 139.76B | -6.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.47B |
| Hansoh Pharmaceutical Group Company | 246.03B |
| JD Health International | 215.18B |
| WuXi Biologics | 155.13B |
| Innovent Biologics | 153.93B |
| Sino Biopharmaceutical | 122.46B |
| Akeso | 116.16B |
| Sichuan Kelun-Biotech Biopharmaceutical | 114.03B |